SpyGlass Pharma Inc. shares jumped 65% in the biopharmaceutical firm’s trading debut after it raised $150 million in an initial public offering. The company’s shares closed at $26.40 each in New York ...

SpyGlass Pharma’s shares are scheduled to begin trading on the Nasdaq Global Select Market today under the ticker symbol "SGP." The offering is expected to close on February 9, 2026, subject to ...

ALISO VIEJO, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- SpyGlass Pharma, Inc. (Nasdaq: SGP) (“SpyGlass Pharma”), a late-stage biopharmaceutical company, today announced the pricing of its initial ...

SpyGlass Pharma, Inc is a late-stage biopharmaceutical company dedicated to transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug ...

Scientists have created a complete map showing how hundreds of possible mutations in a key cancer gene influence tumour growth. The study focused on CTNNB1, a gene that produces the protein β-catenin, ...

A mitochondrial DNA mutation passed down through the maternal line in some Venezuelan families has been linked to severe brain injury and death in healthy patients undergoing routine anesthesia.

Lucknow: Lucknow Municipal Corporation on Tuesday approved a series of civic policy decisions, including revision in licence fees for commercial establishments, changes in mutation charges and ...

Space-induced mutations show potential against antibiotic-resistant bacteria according to experimental results from bacteriophage research conducted aboard the International Space Station. Findings ...